Cutaneous Lupus

Introduction

If you have recently been diagnosed with cutaneous lupus, or your dermatologist is investigating skin changes that may be lupus-related, you are likely trying to understand what comes next. Cutaneous lupus is a long-term autoimmune skin condition, which means it is not something that resolves with a single course of treatment. Instead, it is managed over months and years, with the goal of calming inflammation, protecting the skin, and preventing flares.

This guide explains what cutaneous lupus is, the different forms it takes, how doctors diagnose it, the range of treatments that may be used, and what daily life with the condition typically looks like. It also covers when cutaneous lupus might point toward more widespread (systemic) lupus, and how to recognise warning signs that need urgent attention.

Cutaneous lupus looks different from person to person. Some people experience mild, sun-triggered rashes that come and go. Others develop persistent lesions that can leave scars or pigment changes. Because the condition is variable and often confused with other skin problems, accurate diagnosis and a structured long-term plan make a real difference to outcomes.

What Is Cutaneous Lupus?

Cutaneous lupus, also called cutaneous lupus erythematosus (CLE), is an autoimmune disorder in which the immune system — the body’s defence system — mistakenly attacks healthy skin cells. The result is inflammation that shows up as rashes, scaly patches, raised lesions, or pigment changes on the skin.

The word “cutaneous” means “of the skin.” In cutaneous lupus, the skin is the main organ affected. This is different from systemic lupus erythematosus (SLE), where the immune attack can involve internal organs such as the joints, kidneys, heart, lungs, blood cells, and nervous system. Many people with cutaneous lupus never develop systemic disease. However, some do, and a smaller group have skin findings as part of an existing SLE diagnosis. This is one reason dermatologists evaluate not just the skin, but the wider clinical picture.

Cutaneous lupus is more common in women than men, and most often appears between the ages of 20 and 50, though it can occur at any age. People with darker skin tones may experience more pronounced pigment changes after flares, which is an important consideration in both treatment planning and follow-up.

Types of Cutaneous Lupus

Dermatologists generally divide cutaneous lupus into three main forms, based on how the lesions look and how long they last. Each form behaves differently and is managed in its own way.

Acute Cutaneous Lupus (ACLE)

Acute cutaneous lupus most often appears as a red, flat or slightly raised rash across the cheeks and bridge of the nose. This is sometimes called the “butterfly rash” or malar rash. It can be triggered or worsened by sun exposure and may come on suddenly during a flare. Acute cutaneous lupus has the strongest link with systemic lupus — most people with this form have, or will develop, SLE. Lesions usually heal without scarring, though they may leave temporary pigment changes.

Subacute Cutaneous Lupus (SCLE)

Subacute cutaneous lupus tends to appear on sun-exposed areas such as the upper chest, back, shoulders, and outer arms. The lesions are often scaly and can take two main shapes: ring-like (annular) patches with a clear centre, or scaly patches that resemble psoriasis (papulosquamous). SCLE is strongly photosensitive, meaning sunlight clearly triggers and worsens it. It can also be triggered by certain medications. While SCLE usually does not scar, it can leave long-lasting pigment changes. A proportion of people with SCLE also have systemic features, often mild.

Chronic Cutaneous Lupus (Discoid Lupus and Related Forms)

The most common form of chronic cutaneous lupus is discoid lupus erythematosus (DLE). DLE causes thick, disc-shaped, scaly patches that most often appear on the face, scalp, and ears. Over time, these lesions can leave permanent scarring, pigment changes, and — on the scalp — areas of permanent hair loss called scarring alopecia. Most people with DLE have skin-only disease, but a smaller proportion develop systemic lupus, so periodic monitoring is important.

Less common chronic forms include lupus panniculitis (also called lupus profundus), which affects the deeper fat layer and can leave dents in the skin, and chilblain lupus, which produces painful, cold-sensitive lesions on the fingers, toes, ears, and nose.

Causes and Risk Factors

The exact cause of cutaneous lupus is not fully understood. Like other autoimmune conditions, it is thought to develop when several factors combine in a person who is genetically susceptible.

Genetic Susceptibility

Cutaneous lupus is not directly inherited, but having a close relative with lupus or another autoimmune condition increases the chance of developing it. Researchers have identified a number of gene variants linked to lupus susceptibility, particularly those involved in how the immune system handles cell damage and inflammation.

Environmental and Lifestyle Triggers

• Ultraviolet (UV) light: Sunlight is the most well-established trigger. UV exposure can both bring on new lesions and worsen existing ones. Even brief exposure can sometimes trigger a flare in sensitive people.
• Smoking: Smoking is consistently linked to more severe cutaneous lupus and to reduced response to certain medications, including antimalarial drugs.
• Infections: Some viral infections appear to act as triggers in susceptible individuals.
• Hormones: The condition is more common in women, and hormonal changes during pregnancy or with certain hormonal medications may influence disease activity.
• Stress: Many patients report that physical or emotional stress precedes a flare, although this is harder to study formally.

Drug-Induced Cutaneous Lupus

Certain medications can trigger a lupus-like skin condition, most commonly subacute cutaneous lupus. Drugs that have been linked include some blood pressure medications, antifungals, proton pump inhibitors, and certain biologic therapies. Drug-induced cutaneous lupus often improves once the responsible medication is stopped, though this should always be done in discussion with the prescribing doctor.

Signs and Symptoms

For a reader who has already been diagnosed, this section is less about recognising the condition for the first time and more about understanding what active disease looks like, so you can identify a flare early and know when to seek care.

Common Skin Findings

• Red or purplish patches on the face, particularly across the cheeks and nose
• Scaly, ring-shaped patches on sun-exposed skin
• Disc-shaped, thickened plaques with scaling and a tendency to scar
• Hair loss in patches on the scalp
• Sores or ulcers inside the mouth or nose
• Pigment changes — lighter or darker patches where lesions have healed
• Sensitivity to sunlight, with rashes appearing or worsening within hours or days of exposure

Symptoms That May Point Toward Systemic Involvement

Cutaneous lupus is primarily a skin condition, but it is important to be aware of symptoms that may suggest the immune attack is also affecting other parts of the body. These include:

• Persistent joint pain, stiffness, or swelling
• Unusual fatigue that does not improve with rest
• Unexplained fever
• Chest pain when breathing
• Swelling in the legs or around the eyes
• Foamy or discoloured urine
• Numbness, tingling, or new neurological symptoms

If you notice any of these, tell your dermatologist or general doctor. They may arrange blood and urine tests and, if needed, refer you to a rheumatologist.

Diagnosis

Diagnosing cutaneous lupus usually involves a combination of clinical examination, a skin biopsy, and blood tests. The process aims to confirm the diagnosis, identify the specific subtype, and check whether systemic lupus is also present.

Clinical Examination

A dermatologist will examine the affected areas and ask detailed questions about how the rash started, what makes it worse, whether sun exposure plays a role, and whether you have other symptoms such as joint pain or fatigue. They will also review your medications, since some drugs can trigger lupus-like skin disease.

Skin Biopsy

A skin biopsy is the most reliable way to confirm cutaneous lupus. A small piece of affected skin is removed under local anaesthetic and examined under a microscope. The pattern of inflammation, the location of immune cells, and changes at the boundary between the upper and lower layers of the skin all help confirm the diagnosis. In some cases, a special test called direct immunofluorescence (the lupus band test) is performed to look for immune deposits in the skin.

Blood Tests

Blood tests help determine whether the condition is limited to the skin or whether there are signs of systemic involvement. Tests commonly ordered include:

• Antinuclear antibody (ANA) test: A general screening test for autoimmunity
• Anti-Ro/SSA and anti-La/SSB antibodies: Often positive in subacute cutaneous lupus
• Anti-double-stranded DNA and anti-Smith antibodies: More specific for systemic lupus
• Complement levels (C3, C4): May be low in active systemic disease
• Complete blood count, kidney function, urine analysis: To screen for systemic involvement

A positive ANA does not by itself mean a person has systemic lupus. Your doctor will interpret the results alongside your symptoms and skin findings.

Ongoing Monitoring

Because cutaneous lupus can sometimes evolve into systemic lupus over years, periodic clinical and laboratory follow-up is part of standard care, even when the skin disease is well controlled.

Treatment and Management

Cutaneous lupus is a chronic condition, which means treatment focuses on controlling inflammation, preventing flares, protecting the skin from long-term damage, and improving comfort and appearance. Management is typically long-term and is adjusted over time as disease activity changes. Major dermatology societies, including the American Academy of Dermatology and the European Dermatology Forum, describe a stepped approach that starts with sun protection and topical therapies and progresses to systemic medications when needed.

Sun Protection — The Foundation of Treatment

Sun protection is the single most important part of managing cutaneous lupus, and it is recommended at every stage of disease, regardless of subtype or severity. Practical sun protection includes:

• Daily use of broad-spectrum sunscreen with SPF 50 or higher, applied generously and reapplied every two to three hours when outdoors
• Sunscreen that protects against both UVA and UVB rays, and ideally visible light as well, since visible light can also trigger lesions in some patients (tinted mineral sunscreens with iron oxides are often suggested for this)
• Sun-protective clothing, wide-brimmed hats, and UV-blocking sunglasses
• Avoiding peak sun hours, typically late morning to mid-afternoon
• Awareness that UV light can penetrate through windows, clouds, and light clothing

Strict sun avoidance can lower vitamin D levels, so your doctor may check vitamin D and recommend supplementation if needed.

Topical Treatments

Topical medications — creams, ointments, and gels applied directly to the skin — are usually the first line of medical treatment for mild to moderate disease, and are often continued alongside systemic therapy in more severe cases.

• Topical corticosteroids: Reduce inflammation. The strength is matched to the body area and severity. Stronger steroids are used on thicker skin (such as the trunk or scalp) and milder steroids on the face and folds, with attention to limiting the duration of use to avoid skin thinning.
• Topical calcineurin inhibitors: Medications such as tacrolimus ointment and pimecrolimus cream are non-steroid options that suppress local immune activity. They are often used on the face and other sensitive areas where prolonged steroid use is best avoided.
• Intralesional corticosteroid injections: For thick discoid lesions or stubborn plaques, a dermatologist may inject corticosteroid directly into the lesion to reduce inflammation and scarring risk.

Antimalarial Medications

Antimalarial drugs — particularly hydroxychloroquine — are widely considered the cornerstone of systemic treatment for cutaneous lupus, and are recommended as first-line systemic therapy by major dermatology and rheumatology societies. Despite their name, they are used here for their immune-modulating effects, not as antimalarials.

Hydroxychloroquine takes several weeks to months to reach its full effect. It is generally well tolerated, but long-term use requires periodic eye examinations to screen for a rare effect on the retina. Smoking has been shown to reduce how well antimalarials work, which is one of several reasons stopping smoking is strongly encouraged.

If hydroxychloroquine alone is not enough, chloroquine or quinacrine may be added or substituted, depending on availability and individual response.

Other Systemic Treatments

When skin disease is severe, widespread, scarring, or not responding to antimalarials, doctors may consider additional systemic options:

• Oral corticosteroids: Short courses may be used to bring severe flares under control, but long-term use is avoided where possible because of side effects.
• Methotrexate: A weekly tablet or injection that suppresses immune activity.
• Mycophenolate mofetil: Another immune-suppressing medication used for stubborn disease.
• Azathioprine: Sometimes used as a steroid-sparing option.
• Dapsone: May be considered for certain types of lesions, including bullous (blister-like) lupus.
• Retinoids: Oral vitamin A derivatives may help in hyperkeratotic (thick, scaly) discoid lesions.
• Thalidomide and lenalidomide: Reserved for severe, refractory cases under careful specialist supervision due to significant side effects, including effects on pregnancy and nerves.
• Biologic and newer targeted therapies: Medications such as belimumab and anifrolumab, originally developed for systemic lupus, are increasingly being studied and used for cutaneous disease that does not respond to other treatments. Their role continues to evolve.

Each of these medications has its own benefits and risks, monitoring requirements, and considerations around pregnancy and contraception. The choice depends on your subtype, severity, other health conditions, and a detailed discussion with your dermatologist or rheumatologist.

Treating Pigment Changes and Scars

Once active inflammation has been controlled, residual pigment changes or scars may remain. Options that dermatologists may consider for cosmetic improvement include camouflage makeup, laser therapy (in carefully selected patients and only when disease is inactive), and, rarely, surgical revision of scars. Hair transplantation is sometimes considered for stable, burnt-out discoid lupus of the scalp, again only when disease has been quiet for an extended period.

Lifestyle and Self-Management

Day-to-day choices have a real impact on how cutaneous lupus behaves over time. Many patients find that combining medical treatment with consistent self-care leads to fewer flares and better skin health.

Skincare Routine

• Use gentle, fragrance-free cleansers and moisturisers
• Avoid harsh exfoliants, strong acids, and aggressive cosmetic procedures during active disease
• Patch-test new products on a small area first
• Keep the skin well moisturised, especially in dry climates or air-conditioned environments

Stopping Smoking

Stopping smoking is one of the most impactful lifestyle changes for people with cutaneous lupus. Smoking is associated with more severe disease, more scarring, and a reduced response to antimalarial medication. Support to stop smoking is available through general practitioners and dedicated cessation services.

Diet, Exercise, and General Health

There is no specific “lupus diet,” but a balanced diet rich in fruits, vegetables, whole grains, and healthy fats supports general health and immune function. Regular moderate exercise, adequate sleep, and stress management can also help. If you are on long-term corticosteroids, your doctor may recommend bone-protective measures including calcium, vitamin D, and weight-bearing exercise.

Mental Health and Body Image

Visible skin disease, particularly on the face and scalp, can have a significant emotional impact. Feelings of self-consciousness, low mood, and anxiety are common and valid. Talking to your dermatologist about how the condition is affecting you is appropriate, and referral to psychological support or peer support groups can be helpful.

Monitoring and Follow-Up

Because cutaneous lupus is chronic and can change over time, regular follow-up is part of standard care.

What Monitoring Usually Involves

• Periodic dermatology visits to assess disease activity, treatment response, and side effects
• Blood tests to monitor immune markers and to check for any signs of systemic involvement
• Urine tests to screen for kidney involvement when systemic lupus is a concern
• Annual or more frequent eye examinations for patients on hydroxychloroquine, as recommended by current ophthalmology guidance
• Blood pressure, blood sugar, and bone health checks for patients on long-term corticosteroids
• Vitamin D level checks, given strict sun avoidance

How often you are seen depends on disease activity, the medications you are taking, and whether systemic disease is present.

Complications

With early and consistent treatment, many people with cutaneous lupus avoid serious complications. Understanding what can happen, however, helps you and your doctor work to prevent it.

Scarring and Pigment Changes

Discoid lupus in particular can cause permanent scars, including scarring hair loss on the scalp. Once scarring has occurred, treatment cannot fully reverse it, which is why early control of inflammation is emphasised.

Progression to Systemic Lupus

A proportion of people with cutaneous lupus develop systemic lupus over time. The risk varies by subtype — it is highest in acute cutaneous lupus and lower (but not zero) in isolated discoid lupus. Ongoing monitoring helps catch systemic involvement early.

Medication-Related Effects

Long-term use of corticosteroids can lead to weight gain, raised blood sugar, raised blood pressure, bone thinning, and cataracts. Antimalarials carry a small long-term risk of retinal effects. Immune-suppressing medications can increase infection risk. Regular monitoring is designed to detect any of these effects early.

Skin Cancer in Long-Standing Discoid Lesions

Rarely, long-standing, untreated discoid lupus lesions — particularly on the lips or scalp — can develop into squamous cell carcinoma. Any lesion that changes appearance, ulcerates, or behaves differently from the usual pattern should be reviewed promptly.

Cutaneous Lupus in Children

Cutaneous lupus is less common in children than in adults but does occur. When it appears in childhood, it has some distinct features that affect how it is managed.

Neonatal Lupus

Neonatal lupus is a temporary condition that can affect babies born to mothers who carry anti-Ro/SSA or anti-La/SSB antibodies. It typically causes a ring-shaped rash on the face and scalp that appears within the first weeks of life and resolves over months as maternal antibodies clear from the baby’s system. The skin disease usually leaves no permanent marks. A more serious aspect of neonatal lupus is congenital heart block, which is monitored for during pregnancy and after birth.

Discoid and Subacute Lupus in Children and Adolescents

When discoid or subacute cutaneous lupus appears in children, it is managed along similar lines to adult disease — sun protection, topical therapies, and antimalarial medication where appropriate — but with adjustments to dosing and to monitoring. There is some evidence that children with cutaneous lupus, particularly discoid lupus, may have a higher chance of developing systemic lupus than adults with the same skin findings, so paediatric rheumatology input is often part of care.

Practical Considerations for Families

• School-based sun protection — including indoor seating away from windows and outdoor break planning — can make a real difference
• Children may need help understanding why sun protection is so important, framed in age-appropriate terms
• Visible skin changes can affect a child’s confidence and social experience; teachers, school counsellors, and peer support can all play a role
• Regular paediatric follow-up monitors growth, medication effects, and any signs of systemic disease

Preventing Flares

Once the diagnosis is established and treatment is in place, much of long-term management focuses on preventing flares. While not every flare can be avoided, certain steps consistently reduce their frequency and severity.

• Daily sun protection, year-round: The most reliable single measure
• Adherence to prescribed medication: Antimalarials in particular need to be taken consistently to maintain their effect
• Stopping smoking: Reduces disease severity and improves treatment response
• Reviewing medications: If a new medication is started, mention your cutaneous lupus to the prescribing doctor, as some drugs can trigger flares
• Recognising early flare signs: Catching a flare early often means it can be controlled with less treatment
• Managing stress and rest: Where possible, balancing activity with adequate rest

When to Seek Urgent Care

Most changes in cutaneous lupus can be managed at routine appointments. However, some situations warrant prompt medical attention:

• Rapidly spreading rash or large new ulcerated areas
• Painful, hot, or pus-producing skin lesions, which may indicate infection
• Persistent fever, particularly while taking immune-suppressing medication
• Severe joint pain, chest pain, breathlessness, or swelling of the legs
• Foamy or bloody urine, which may suggest kidney involvement
• New neurological symptoms such as severe headache, vision changes, weakness, or confusion
• Signs of a serious medication reaction, including widespread rash, blistering, mouth ulcers, or facial swelling

Any of these should prompt contact with your doctor or, when severe, urgent medical assessment.

Living with Cutaneous Lupus

Cutaneous lupus is a long-term condition, but it is not one that has to dominate daily life. Many people, once their treatment is established and sun protection becomes habit, find that the condition becomes a manageable background presence rather than a constant concern. Periods of stable, quiet disease are common, particularly with consistent treatment and trigger avoidance.

It is worth being patient with treatment. Improvement is gradual: topical treatments may show effect over weeks, antimalarials over two to three months, and lesions and pigment changes can take many months to settle even after inflammation is controlled. Setting realistic expectations with your dermatologist at the start helps avoid frustration along the way.

Support from others — family, friends, patient organisations, and online communities — can be valuable, especially during flares or when adjusting to a new diagnosis. Mental health support is a legitimate and important part of care.

Frequently Asked Questions

Is cutaneous lupus the same as systemic lupus?

No. Cutaneous lupus primarily affects the skin, while systemic lupus involves internal organs. Many people with cutaneous lupus never develop systemic disease, but because some do, ongoing monitoring is part of standard care.

Can cutaneous lupus be cured?

Cutaneous lupus is usually a long-term condition rather than something that is permanently cured. With consistent treatment, however, many people achieve long periods of quiet, stable disease with few or no visible lesions.

Does sunlight really make cutaneous lupus worse?

Yes. Sun exposure is the most consistent trigger for new lesions and flares across all forms of cutaneous lupus. Daily, year-round sun protection is recommended by all major dermatology guidelines.

Is cutaneous lupus contagious?

No. Cutaneous lupus is an autoimmune condition. It cannot be passed from one person to another through contact, sharing items, or any other route.

Can I wear makeup over the rashes?

Generally yes, once active inflammation is under control. Mineral-based, fragrance-free, non-comedogenic products are usually tolerated well. Specialised camouflage makeup can help cover pigment changes and scars. It is sensible to discuss product choices with your dermatologist if your skin is very sensitive.

Will I pass cutaneous lupus on to my children?

Cutaneous lupus is not directly inherited. There is a small increased risk of autoimmune conditions in close relatives, but most children of parents with cutaneous lupus do not develop it. If you are pregnant and carry certain antibodies, your doctor may recommend specific monitoring for neonatal lupus during pregnancy.

Can I get pregnant if I have cutaneous lupus?

Many people with cutaneous lupus have healthy pregnancies, particularly when disease is well controlled. However, some lupus medications are not safe in pregnancy, so planning ahead with your dermatologist and obstetrician is important. Hydroxychloroquine is generally considered safe and is often continued during pregnancy.

How long does it take for treatment to work?

Topical treatments may begin to help within a few weeks. Antimalarials such as hydroxychloroquine typically take two to three months to reach their full effect. Other systemic treatments often need several weeks before improvement is clear. Pigment changes and scars take much longer to fade and may not fully resolve.

Do I need to see a rheumatologist as well as a dermatologist?

This depends on your subtype, the results of your blood tests, and whether you have any symptoms suggesting systemic involvement. Many people with skin-limited disease are managed by a dermatologist alone, with referral to a rheumatologist if needed.

Conclusion

Cutaneous lupus is a chronic autoimmune skin condition that can be unpredictable, but it is a condition for which treatment options have expanded significantly in recent years. The cornerstones of care — strict sun protection, well-chosen topical and systemic medications, monitoring for systemic involvement, and attention to triggers such as smoking — are well established and effective for most patients.

While cutaneous lupus is rarely cured outright, modern dermatology care allows the majority of people to achieve stable, comfortable skin and to limit long-term damage. Early diagnosis, a clear long-term plan with your dermatologist, and consistent self-care are the foundations on which good outcomes are built.